Cord Blood Stem Cells and Treatment Resistant Depression
This is a collaborative post with Cells4Life.
In recent years, there has been a notable paradigm shift in the medical field regarding the perception and utilisation of biological resources. Cord blood, previously considered clinical waste after childbirth, has emerged as a pioneering example of medical advancement. This transformation raises crucial inquiries concerning the potential medical innovations that could arise from this previously disregarded biological material.
Traditionally, cord blood, found in the umbilical cord and placenta post-delivery, was typically disposed of as clinical waste. However, advancements in medical research have uncovered the abundant presence of stem cells within cord blood. These stem cells possess remarkable regenerative capabilities, showing promise in treating a wide spectrum of medical conditions, spanning from blood disorders to immune deficiencies and various forms of cancer. This newfound insight has led to a reevaluation of cord blood’s significance, transitioning it from mere waste to a valuable resource capable of revolutionising modern medicine.
The potential applications of these stem cells are vast; today over 80 conditions are treated with cord blood stem cells as an approved therapy which include ailments such as leukaemia, lymphoma, and certain autoimmune disorders. There are thousands of clinical trials taking place to further explore the potential of cord blood stem cells in a variety of conditions, including Treatment Resistant Depression.
A recent study investigating the use of umbilical cord blood cells yielded promising outcomes. In this study women experiencing Treatment Resistant Depression, and their outcomes were compared against a control group receiving a placebo. The test group received concentrated umbilical cord blood cells which were administered via a dose of millions of cells through weekly injections over a span of 4 weeks, with 1-week intervals.
The research indicated that the concentrated umbilical cord blood cell treatment showed potential in addressing treatment resistance observed in patients with depression. Moreover, additional studies have similarly suggested that cellular therapies may play a role in addressing Treatment Resistant Depression.
These findings offer hope for the development of novel treatments. Through the utilisation of umbilical cord blood cells, individuals grappling with Treatment Resistant Depression may envision a future where relief from this debilitating condition is attainable, thus enhancing their quality of life.
Cord blood banking offers parents the opportunity to save their baby’s cord blood offering a form of assurance akin to an insurance policy, it ensures that if the need arises, stem cell therapy remains within reach. It also provides access to new and emerging therapies as well as clinical trials. Based on their experience with other types of cell storage, the scientific consensus is that cord blood stem cells will be viable for storage indefinitely, ensuring that they are available when they are needed the most – in old age.
Pin It!
